Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Exp Hematol. 2013 Feb 19;41(6):518–529.e5. doi: 10.1016/j.exphem.2013.02.006

Table 3.

Targeted gene re-sequencing in tumors from Hoxa9 mice.

Sample ID Tissue Notch1 5′ del mutation Notch1 HD Exon 26 Notch1 HD Exon 27 Notch1 JM Exon 28 Notch1 PEST domain Exon 34 Fbxw7 Exon 8 Fbxw7 Exon 9 Bcl11b del mutation Pten (RT-PCR)
1077 Thy GL GL GL GL 66353CC > TTTG GL GL GL GL
1118 Sp GL GL 59855AAGA > TAAG (Lys-Ser > STOP-Gly) GL 66336C > GG GL GL GL GL
1125 Thy P GL GL GL 66282CT > GCG GL GL GL GL
1138 Sp GL GL 59724T > C(Leu > Pro) GL GL GL GL GL 388C > T, Arg > Trp

Sp: spleen, Thy: thymus

HD: heterodimerization domain, JM: juxtamembrane domain

PEST: Proline/Glutmaic Acid/Serine/Threonine domain

GL, germline; P, positive for 5′ del mutation